CLOSE X

EMCURE PHARMACEUTICALS LTD.

NSE : EMCUREBSE : 544210ISIN CODE : INE168P01015Industry : Pharmaceuticals & DrugsHouse : Private
BSE1732.85123.7 (+7.69 %)
PREV CLOSE ( ) 1609.15
OPEN PRICE ( ) 1660.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 60253
TODAY'S LOW / HIGH ( )1653.50 1770.05
52 WK LOW / HIGH ( )950 1770.05
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 16-04 1981
Management Info
Berjis Desai - Chairman Satish Mehta - Managing Director
Registered Office

Address Plot No. P-1 & P-2,I T - B T Park, Phase- I I,M I D C, Hinjawadi,
Pune,
Maharashtra-411057

Phone 020-35070033 / 35070000

Email corporate@emcure.com

Website www.emcure.com

Registrars Details
MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
02Apr Emcure Pharmaceuticals reduces Poviztr
Emcure Pharmaceuticals has reduced price of its weight management drug P..
10Mar Emcure Pharmaceuticals informs about c
Emcure Pharmaceuticals has informed that this is with reference to email..
04Mar Emcure Pharmaceuticals moves up on sig
Emcure Pharmaceuticals is currently trading at Rs. 1452.40, up by 6.50 p..
02Mar Emcure Pharmaceuticals signs distribut
Emcure Pharmaceuticals has signed a distribution agreement with Roche fo..
22Dec Emcure Pharmaceuticals launches semagl
Emcure Pharmaceuticals has launched Poviztra, semaglutide injection, acr..
Financials
Rs. in Millions
QTR Dec 25 ANNUAL 25
Net Profit2588.513171.28
Gross Profit 3143.65 4277.1
Operating Profit 4388.047656.44
Net Sales 14183.0843819.24
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Neuland Laboratories (BSE)
 14652.50 (1.44%)
M.Cap ( in Cr)18798.99
Sanofi Cons. Health (BSE)
 4799.15 (2.66%)
M.Cap ( in Cr)11052.74
Abbott India (BSE)
 25484.55 (0.47%)
M.Cap ( in Cr)54152.89
Divi's Lab (BSE)
 6535.00 (1.57%)
M.Cap ( in Cr)173483.72
Concord Biotech (BSE)
 1131.90 (5.68%)
M.Cap ( in Cr)11841.51
Shareholding Pattern
PROMOTERS 77.87%
NON-INSTITUTION 12.69%
MUTUAL FUNDS/UTI 4.94%
FI/BANKS/INSURANCE 0.87%
GOVERNMENT 0%
FII 0%

Badjate Stock & Shares Pvt. Ltd.
201, Mangalam Arcade,
Above Venus Book Centre, Dharampeth Extn. Nagpur - 440010 Maharashtra, India.

Advisory for Investors Complaints Data February 2026 Broking Complaints Data February 2026 DP

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal(https://scores.sebi.gov.in/)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
Process Flow of Complaint Redressal Mechanism

Details of Client Bank account of Badjate Stock & Shares Private Limited:

  • 1)Client Bank account Number : 01020340001341 / 57500000546632
  • 2)Name of Bank Account :
    BADJATE STOCK AND SHARES PRIVATE LIMITED - USCNB Account
  • 3)IFSC : HDFC0000102
  • 4)BRANCH : Shankar Nagar / Dharampeth Extn Nagpur
  • 5)MICR – 440240002

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html We believe that an educated investor is a protected investor !!!

ATTENTION INVESTORS| KYC | IPO | CLIENT BANK A/C| DIRECT ON-BOARDING FOR PMS SERVICES

© Badjate Group 2018

Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.